These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20048394)

  • 41. [Balloon angioplasty for the treatment of the drug-eluting stent restenosis in a patient with multivessel coronary artery disease and muscular bridge].
    Pawłowski T; Kulawik T; Rzezak J
    Kardiol Pol; 2008 Nov; 66(11):1229-31; discussion 1232. PubMed ID: 19105104
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug-eluting versus bare metal stents--a one horse race?
    Meier P; Gurm HS
    J Invasive Cardiol; 2010 Jan; 22(1):33-4. PubMed ID: 20048397
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures.
    Sharp AS; Latib A; Ielasi A; Larosa C; Godino C; Saolini M; Magni V; Gerber RT; Montorfano M; Carlino M; Michev I; Chieffo A; Colombo A
    Circ Cardiovasc Interv; 2009 Oct; 2(5):416-22. PubMed ID: 20031751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-eluting stents: a critique.
    Melikian N; Wijns W
    Heart; 2008 Feb; 94(2):145-52. PubMed ID: 18195121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
    Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of shear stress on in-stent restenosis and thrombosis.
    Wentzel JJ; Gijsen FJ; Schuurbiers JC; van der Steen AF; Serruys PW
    EuroIntervention; 2008 Aug; 4 Suppl C():C27-32. PubMed ID: 19202688
    [No Abstract]   [Full Text] [Related]  

  • 48. Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
    Kandzari DE; Farb A; Boam AB
    Circ Cardiovasc Interv; 2009 Dec; 2(6):574-9. PubMed ID: 20031776
    [No Abstract]   [Full Text] [Related]  

  • 49. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria.
    Carlsson J; James SK; Lindbäck J; Scherstén F; Nilsson T; Stenestrand U; Lagerqvist B;
    J Am Coll Cardiol; 2009 Apr; 53(16):1389-98. PubMed ID: 19371822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Debating the risks of drug-eluting stents.
    Shuchman M
    N Engl J Med; 2007 Jan; 356(4):325-8. PubMed ID: 17251527
    [No Abstract]   [Full Text] [Related]  

  • 52. TCT Daily: ESTROFA: late thrombosis not increased in DES patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors.
    Kahn J
    J Interv Cardiol; 2007 Feb; 20(1):32. PubMed ID: 17300396
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug-eluting stent safety.
    Slottow TL; Waksman R
    Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 58. Vasoconstriction and coronary artery spasm after drug-eluting stent placement.
    Togni M; Eberli FR
    J Invasive Cardiol; 2006 Dec; 18(12):593. PubMed ID: 17197708
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of restenosis in drug-eluting stents: still a challenge!
    Gupta M; Kadakia J; Budoff MJ
    J Invasive Cardiol; 2010 May; 22(5):220-1. PubMed ID: 20440038
    [No Abstract]   [Full Text] [Related]  

  • 60. A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients.
    Baran KW; Lasala JM; Cox DA; Mascioli SR; Song A; Deshpande MC; Jacoski MV; Dawkins KD;
    EuroIntervention; 2011 Mar; 6(8):949-54. PubMed ID: 21330242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.